HIGHLIGHTS
SUMMARY
Multiple studies have shown that LAI antipsychotics have benefits in reducing relapses, hospitalizations, general morbidity, and mortality in schizophrenia patients. Patients (24.44%) were stabilized on LAI treatment (LAI subgroup) and 238 (75.56%) patients on oral treatment (OAP subgroup); 18 patients (5.71%) were stabilized on combined antipsychotic, LAI, and oral treatment. In the LAI group, 39 patients (50.64%) were stabilized on second-generation LAI antipsychotics (SGA-LAI group) and 38 patients (49.36%) on first-generation LAI antipsychotics (FGA-LAI group). In the SGA-LAI group, 23 patients (58.97%) were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.